Inequities in diabetes prevention and control in fragile, conflict-affected and vulnerable settings: a mixed-methods study from the WHO Eastern Mediterranean Region
Authors:
Open Access
Abstract
Objectives: To evaluate progress in the implementation of the WHO Eastern Mediterranean Regional Office (EMRO) Regional Framework for Action on Diabetes Prevention and Control, identify implementation barriers and facilitators, and provide recommendations for accelerating progress, with a particular focus on fragile, conflict-affected and vulnerable settings (FCVs). Design: Mixed-methods study combining secondary analysis of quantitative data from WHO datasets with qualitative synthesis of inputs from WHO consultative meetings with EMR member states. Setting: 22 countries of the WHO EMR, including 10 classified as FCV and 12 as non-FCV according to World Bank and WHO classifications. Participants: Quantitative data were drawn from the 2021 WHO Country Capacity Survey targeting all EMR countries and other WHO sources. Qualitative data were based on insights from 16 country representatives during a regional WHO EMRO webinar, including non-communicable diseases programme managers, policy leads and WHO country office staff. Results: Among the 22 countries analysed, only 10% (1/10) of FCVs had a national diabetes action plan compared with 67% (8/12) of non-FCVs. A sugar-sweetened beverage tax was implemented in 75% (9/12) of non-FCVs but in just 10% (1/10) of FCVs. For diabetes management, detailed national guidelines were available in 30% (3/10) of FCVs compared with 83% (10/12) of non-FCVs; insulin was available in primary care in 50% (5/10) of FCVs compared with 83% (10/12) of non-FCVs. Surveillance systems were less robust in FCVs: while 70% (7/10) collected data on diabetes status, only 30% (3/10) had a national diabetes registry, compared with 83% (10/12) of non-FCVs. Conclusions: Addressing diabetes in the EMR requires strategic collaboration and tailored approaches for FCVs, including strengthened governance, preparedness, integrated care, medication access and surveillance. Prioritising primary healthcare and embedding diabetes prevention and control in universal health coverage and emergency response frameworks is critical to reducing inequities and improving health outcomes in fragile contexts.Keywords
Funding Information
- World Health Organization
This publication has 17 references indexed in Scilit:
- An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settingsThe Lancet Diabetes & Endocrinology, 2022
- The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adultsThe Lancet Healthy Longevity, 2021
- Committing to implementation research for health systems to manage and control non-communicable diseasesThe Lancet Global Health, 2021
- Dynamics of non-communicable disease prevention, diagnosis and control in Lebanon, a fragile settingConflict and Health, 2021
- The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billionThe Lancet, 2020
- Diabetes in humanitarian crises: the Boston DeclarationThe Lancet Diabetes & Endocrinology, 2019
- The Management of Diabetes in Conflict Settings: Focus on the Syrian CrisisDiabetes Spectrum, 2019
- Health financing in fragile and conflict-affected settings: What do we know, seven years on?Social Science & Medicine, 2019
- Non-communicable diseases in humanitarian settings: ten essential questionsConflict and Health, 2017
- Non-Communicable Diseases in Emergencies: A Call to ActionPLoS Currents, 2013